Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT07890480Recruiting
Aztreonam-Avibactam in Immunocompromised Hosts
Carbapenem-Resistant Enterobacteriaceae InfectionDrug Resistance, Multiple, BacterialEnterobacteriaceae Infections+1 more
StudychairStart date: 2026-10-14

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

CEMIC - Centro de Educación Médica e Investigaciones Clínicas "Dr. Norberto Quirno"

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Diego Torres, MD

CEMIC - Centro de Educación Médica e Investigaciones Clínicas "Dr. Norberto Quirno"

Moderately Similar
1 trials

Shared therapeutic areas:

Carbapenem-Resistant Enterobacteriaceae InfectionDrug Resistance, Multiple, BacterialEnterobacteriaceae Infections+1 more

Worked with same sponsors:

Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Collaborated on 1 trial
Similarity Score44%

Maximiliano Gabriel Castro, MD

CEMIC - Centro de Educación Médica e Investigaciones Clínicas "Dr. Norberto Quirno"

Moderately Similar
1 trials

Shared therapeutic areas:

Carbapenem-Resistant Enterobacteriaceae InfectionDrug Resistance, Multiple, BacterialEnterobacteriaceae Infections+1 more

Worked with same sponsors:

Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Collaborated on 1 trial
Similarity Score44%

Zhaohui Zhu

Peking Union Medical College Hospital

Related
7 trials

Shared therapeutic areas:

Enterobacteriaceae Infections
Similarity Score8%

Kat Kwiatkowski, PhD

Karius, Inc.

Related
2 trials

Shared therapeutic areas:

Immunocompromised Host
Similarity Score8%

Carlo Torti

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Related
2 trials

Shared therapeutic areas:

Carbapenem-Resistant Enterobacteriaceae Infection
Similarity Score8%

Juan José Castón Osorio, MD

Hospital General Universitario Reina Sofía de Murcia

Related
2 trials

Shared therapeutic areas:

Carbapenem-Resistant Enterobacteriaceae Infection
Similarity Score8%

Sanjay K Jain, MD

Johns Hopkins University

Related
5 trials

Shared therapeutic areas:

Enterobacteriaceae Infections
Similarity Score8%

Cristina Mussini, MD

University of Modena and Reggio Emilia

Related
1 trials

Shared therapeutic areas:

Enterobacteriaceae Infections
Similarity Score8%

Thirumalaisamy Velavan, PhD

University of Tübingen, Germany

Related
1 trials

Shared therapeutic areas:

Carbapenem-Resistant Enterobacteriaceae Infection
Similarity Score8%

Roni Bitterman, MD

Rambam Health Care Campus

Related
2 trials

Shared therapeutic areas:

Enterobacteriaceae Infections
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07890480StudyChair

Aztreonam-Avibactam in Immunocompromised Hosts

Carbapenem-Resistant Enterobacteriaceae InfectionDrug Resistance, Multiple, BacterialEnterobacteriaceae Infections+1 more
Recruiting

All 1 trials loaded